Skip to main content
Year archive

STARPHARMA HOLDINGS LIMITED — 2016 filings

All 52 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2016, sourced directly from the official regulator.

52 Filings
2016 Period
2016 filings (52)
Filing Released Lang
Starpharma receives $3.5M R&D tax incentive refund 2 pages 98.1KB
Regulatory Filings
2016-12-21 English
Change in Director's Interest Notice - R Thomas 2 pages 77.6KB
Director's Dealing
2016-12-04 English
Appendix 3B 10 pages 119.7KB
Share Issue/Capital Change
2016-12-04 English
Change in Director's Interest Notice - J Fairley 3 pages 76.4KB
Director's Dealing
2016-12-04 English
AGM - Chairman address and CEO presentation 45 pages 10.5MB
AGM Information
2016-11-28 English
2016 AGM Results 3 pages 99.4KB
Declaration of Voting Results & Voting Rights Announcements
2016-11-28 English
Starpharma signs license for VivaGel Condom in Iran 3 pages 98.4KB
Regulatory Filings
2016-11-27 English
Starpharma to present at Bio-Europe conference 2 pages 97.5KB
Investor Presentation
2016-11-07 English
Additional Priostar Glyphosate Patent Allowed in US 2 pages 181.0KB
Regulatory Filings
2016-10-27 English
Appendix 4C - Quarterly Cashflow Report 6 pages 304.6KB
Interim / Quarterly Report
2016-10-27 English
Notice of Annual General Meeting/Proxy Form 12 pages 525.2KB
AGM Information
2016-10-25 English
Starpharma to present at US Drug Delivery Conference 2 pages 89.5KB
Investor Presentation
2016-10-25 English
Starpharma to present at ASX Spotlight in Asia 2 pages 180.3KB
Investor Presentation
2016-10-24 English
Change in Director's Interest Notice - R Thomas 2 pages 77.5KB
Director's Dealing
2016-10-16 English
Enrolment complete for Phase 3 VivaGel BV-R program 3 pages 106.2KB
Regulatory Filings
2016-10-12 English
Appendix 3B 9 pages 118.0KB
Share Issue/Capital Change
2016-10-12 English
Change in Director's Interest Notice - J Fairley 2 pages 74.9KB
Director's Dealing
2016-10-12 English
Appendix 3B 9 pages 154.8KB
Share Issue/Capital Change
2016-10-06 English
Change in Director's Interest Notice - J Fairley 2 pages 76.2KB
Director's Dealing
2016-10-06 English
Notification of AGM date 2 pages 95.5KB
AGM Information
2016-10-02 English
Change in Director's Interest Notice - R Thomas 2 pages 77.5KB
Director's Dealing
2016-09-18 English
Change in substantial holding 4 pages 130.7KB
Major Shareholding Notification
2016-09-13 English
VivaGel condom receives regulatory approval in Canada 2 pages 942.7KB
Regulatory Filings
2016-09-12 English
Appendix 4E - Correction to NTA Backing 3 pages 199.9KB
Earnings Release
2016-08-30 English
Starpharma Highlights of FY2016 Presentation 12 pages 1.6MB
Investor Presentation
2016-08-29 English
Annual report and full year financial results 91 pages 2.9MB
Annual Report
2016-08-28 English
Appendix 4G - Corporate Governance Statement 10 pages 144.1KB
Governance Information
2016-08-28 English
New DEP drug delivery program initiated with AstraZeneca 2 pages 84.8KB
Regulatory Filings
2016-07-27 English
Starpharma signs license for a VivaGel condom in China 3 pages 122.3KB
Capital/Financing Update
2016-07-20 English
Appendix 4C - Quarterly Cashflow Reoprt 6 pages 119.6KB
Interim / Quarterly Report
2016-07-13 English
Change in substantial holding 3 pages 206.5KB
Major Shareholding Notification
2016-06-13 English
Starpharma's DEP eliminates cabazitaxel neutropenia 4 pages 173.8KB
Regulatory Filings
2016-05-24 English
Change in Director's Interest Notice - R Thomas 2 pages 78.6KB
Director's Dealing
2016-05-18 English
Starpharma to present at ASX CEO Session 2 pages 83.2KB
Investor Presentation
2016-05-16 English
VivaGel active against Zika virus 3 pages 100.4KB
Regulatory Filings
2016-05-04 English
Appendix 4C - Quarterly Cashflow Report 6 pages 175.3KB
Interim / Quarterly Report
2016-04-27 English
Shareholder Update April 2016 4 pages 1.4MB
Interim / Quarterly Report
2016-04-12 English
Starpharma to present at Bio-Europe conference 2 pages 82.8KB
Investor Presentation
2016-04-04 English
DEP cabazitaxel shows complete, sustained tumour regression 4 pages 178.8KB
Regulatory Filings
2016-04-03 English
Adama Licenses Starpharma's Priostar for Novel 2,4-D 3 pages 117.4KB
Regulatory Filings
2016-03-16 English
Starpharma licences VivaGel BV to Aspen for ANZ 3 pages 176.5KB
Capital/Financing Update
2016-03-03 English
Change in substantial holding 2 pages 182.3KB
Major Shareholding Notification
2016-02-23 English
Interim Report and Half-Year Financial Results 22 pages 624.7KB
Interim / Quarterly Report
2016-02-16 English
Targeted DEP shows sustained superior performance 5 pages 271.3KB
Regulatory Filings
2016-02-01 English
Appendix 4C - Quarterly Cashflow Report 6 pages 160.5KB
Interim / Quarterly Report
2016-01-27 English
Change in Director's Interest Notice - R Thomas 2 pages 162.2KB
Director's Dealing
2016-01-26 English
Change in Director's Interest Notice - J Fairley 2 pages 175.9KB
Director's Dealing
2016-01-26 English
Change in Director's Interest Notice - P Turvey 2 pages 160.6KB
Director's Dealing
2016-01-26 English
Change in Director's Interest Notice - Z Peach 2 pages 161.6KB
Director's Dealing
2016-01-26 English
Appendix 3B 8 pages 159.0KB
Capital/Financing Update
2016-01-24 English
Appendix 3B - SPP 8 pages 154.3KB
Capital/Financing Update
2016-01-21 English
Starpharma raises $1.9M under Share Purchase Plan 2 pages 95.2KB
Capital/Financing Update
2016-01-19 English